Paul Coppo Selected Research

Transplantation

1/2018	Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.
4/2007	Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity.
7/2004	Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.
5/2002	[Pathophysiology of thrombotic microangiopathies: current understanding].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Coppo Research Topics

Disease

75	Thrombotic Thrombocytopenic Purpura 03/2022 - 05/2002
35	Thrombotic Microangiopathies 05/2022 - 10/2002
16	acquired Thrombotic thrombocytopenic purpura 01/2021 - 03/2010
13	Thrombocytopenia (Thrombopenia) 01/2020 - 01/2009
12	Neoplasms (Cancer) 01/2019 - 05/2002
10	Hemolytic Anemia 01/2020 - 12/2006
8	Hemolytic-Uremic Syndrome 05/2022 - 05/2002
8	Infections 10/2018 - 05/2002
6	Cytopenia 01/2021 - 11/2004
6	Lymphoma (Lymphomas) 01/2021 - 01/2014
6	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 12/2006
5	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2008
4	Thrombosis (Thrombus) 01/2022 - 01/2003
4	Hemolysis 01/2021 - 01/2014
4	Ischemia 01/2019 - 01/2009
3	Hypertension (High Blood Pressure) 05/2022 - 01/2019
3	Hemorrhage 01/2020 - 07/2015
3	Anemia 06/2019 - 09/2016
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2014 - 05/2008
3	Renal Insufficiency (Renal Failure) 01/2014 - 02/2008
3	HIV Infections (HIV Infection) 03/2012 - 07/2004
2	Atypical Hemolytic Uremic Syndrome 05/2022 - 11/2020
2	Proteinuria 02/2022 - 01/2022
2	Purpura 01/2022 - 11/2018
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2021 - 02/2010
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2020 - 11/2018
2	Disease Progression 01/2020 - 01/2012
2	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 07/2004
2	Stroke (Strokes) 06/2019 - 10/2018
2	Hematologic Neoplasms (Hematological Malignancy) 09/2014 - 11/2004
2	Sepsis (Septicemia) 09/2014 - 04/2007
2	Neutropenia 03/2013 - 11/2004
2	Connective Tissue Diseases (Connective Tissue Disease) 03/2012 - 05/2002
2	Diarrhea 03/2009 - 05/2002
1	Immunoglobulin G4-Related Disease 03/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2021
1	Large Granular Lymphocytic Leukemia 10/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Pre-Eclampsia (Preeclampsia) 11/2020
1	Eclampsia 11/2020
1	Inflammation (Inflammations) 10/2020
1	Epistaxis (Nosebleed) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020

Drug/Important Bio-Agent (IBA)

50	thiamine triphosphorate (TTP)IBA 02/2022 - 05/2002
17	Rituximab (Mabthera)FDA Link 01/2021 - 03/2010
15	AutoantibodiesIBA 11/2021 - 11/2004
11	DisintegrinsIBA 01/2021 - 01/2009
11	Metalloproteases (Metalloproteinases)IBA 01/2021 - 01/2009
10	von Willebrand FactorIBA 11/2021 - 01/2009
10	ThrombospondinsIBA 01/2021 - 01/2009
8	caplacizumabIBA 03/2022 - 01/2019
7	AntibodiesIBA 11/2020 - 07/2004
6	ADAMTS13 ProteinIBA 01/2021 - 01/2009
6	EnzymesIBA 11/2020 - 03/2009
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 11/2004
5	Biological ProductsIBA 03/2022 - 08/2009
5	Immunoglobulin G (IgG)IBA 03/2022 - 01/2014
5	eculizumab FDA Link 01/2021 - 04/2013
4	Shiga Toxin (Shigella Toxin)IBA 05/2022 - 05/2002
4	Etoposide (VP 16)FDA LinkGeneric 04/2021 - 05/2013
4	SteroidsIBA 01/2020 - 11/2004
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2015 - 06/2010
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015 - 06/2010
4	Ferritins (Ferritin)IBA 11/2014 - 05/2008
3	Gemcitabine FDA Link 01/2021 - 01/2019
3	AntigensIBA 01/2020 - 03/2013
3	Antinuclear AntibodiesIBA 04/2017 - 07/2004
2	CreatinineIBA 01/2022 - 11/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2018
2	Complement System Proteins (Complement)IBA 11/2020 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 12/2019 - 11/2014
2	Triglycerides (Triacylglycerol)IBA 11/2014 - 09/2014
2	Fibrinogen (Factor I)FDA Link 09/2014 - 03/2009
2	Monoclonal AntibodiesIBA 01/2014 - 03/2009
2	Hemostatics (Antihemorrhagics)IBA 02/2013 - 03/2009
2	Complement Factor H (Factor H)IBA 03/2009 - 03/2004
2	Pharmaceutical PreparationsIBA 02/2008 - 11/2004
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	ruxolitinibIBA 10/2021
1	Ifosfamide FDA LinkGeneric 04/2021
1	Brentuximab VedotinIBA 04/2021
1	Carboplatin (JM8)FDA LinkGeneric 04/2021
1	HaptoglobinsIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	EpitopesIBA 11/2020
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020

Therapy/Procedure

16	Plasma Exchange 01/2020 - 10/2002
14	Therapeutics 01/2022 - 02/2008
6	Drug Therapy (Chemotherapy) 01/2021 - 05/2002
4	Transplantation 01/2018 - 05/2002
3	Hematopoietic Stem Cell Transplantation 01/2017 - 03/2013
2	Catheters 01/2020 - 07/2015
2	Highly Active Antiretroviral Therapy (HAART) 12/2017 - 06/2010
2	Salvage Therapy 08/2016 - 11/2012
2	Platelet Transfusion (Blood Platelet Transfusions) 07/2015 - 06/2015
1	Critical Care (Surgical Intensive Care) 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021